Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription


2 AJR Am J Roentgenol
7 Am J Gastroenterol
1 Am J Pathol
2 BMC Cancer
5 Br J Surg
1 Cancer Res
1 Dig Dis Sci
7 Eur Radiol
3 Gastroenterology
2 Gut
3 Hepatology
1 Indian J Gastroenterol
1 J Clin Oncol
5 J Hepatol
2 J Pediatr Surg
1 Oncogene
1 PLoS Genet
4 PLoS One
1 Radiology
4 Transplant Proc

    AJR Am J Roentgenol

  1. KIM TK
    Editorial Comment: Differentiating Hepatic Adenomas From Focal Nodular Hyperplasias With Gadoxetic Acid-Enhanced MRI-More Complicated Than Thought.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28384.
    >> Share

  2. ISEKE S, Zeevi T, Kucukkaya AS, Raju R, et al
    Machine-Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28077.
    >> Share

    Am J Gastroenterol

  3. WENTWORTH BJ, Henry ZH, Siragy HM
    How I Approach It: Adrenal Insufficiency in Cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00445.
    >> Share

  4. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    >> Share

  5. MOON AM, Ioannou GN
    Moving Away from a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance.
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00430.
    >> Share

  6. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    >> Share

  7. DAJTI E, Ravaioli F, Marasco G, Alemanni LV, et al
    A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00415.
    >> Share

  8. BHAVSAR-BURKE I, Guardiola JJ, Hamade N, Gerke S, et al
    Use of a cirrhosis admission order set improves adherence to quality metrics and may decrease hospital length of stay.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00463.
    >> Share

  9. KUTMUTIA R, Tittanegro T, China L, Forrest E, et al
    Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00458.
    >> Share

    Am J Pathol

  10. DONG MP, Thanh Thuy LT, Hoang DV, Hai H, et al
    Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus-Sustained Virological Response Patients.
    Am J Pathol. 2022 Aug 11. pii: S0002-9440(22)00207.
    >> Share

    BMC Cancer

  11. ZHANG G, Lv X, Yang Q, Liu H, et al
    Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.
    BMC Cancer. 2022;22:888.
    >> Share

  12. AMBROZKIEWICZ F, Trailin A, Cervenkova L, Vaclavikova R, et al
    CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence.
    BMC Cancer. 2022;22:884.
    >> Share

    Br J Surg

  13. HUO TI, Ho SY, Liao JI
    Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670908. doi: 10.1093.
    >> Share

  14. HOBEIKA C, Cauchy F
    Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
    Br J Surg. 2022 Aug 18. pii: 6670912. doi: 10.1093.
    >> Share

    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    >> Share

  16. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    >> Share

  17. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    >> Share

    Cancer Res

  18. BARTON MC, Lozano G
    p53 Activation Paradoxically Causes Liver Cancer.
    Cancer Res. 2022;82:2824-2825.
    >> Share

    Dig Dis Sci

  19. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    >> Share

    Eur Radiol

  20. CHERNYAK V, Tang A, Do RKG, Kamaya A, et al
    Liver imaging: it is time to adopt standardized terminology.
    Eur Radiol. 2022;32:6291-6301.
    >> Share

  21. JOO I, Morrow KW, Raman SS, McWilliams JP, et al
    CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Eur Radiol. 2022;32:6327-6335.
    >> Share

  22. VIETTI VIOLI N, Gnerre J, Law A, Hectors S, et al
    Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
    Eur Radiol. 2022;32:6493-6503.
    >> Share

  23. WANG H, Guo Y, Yan B, Zhang Q, et al
    Development and validation of a prediction model based on clinical and CT features for invasiveness of K. pneumoniae liver abscess.
    Eur Radiol. 2022;32:6397-6406.
    >> Share

  24. SALEH GA, Elmokadem AH, Razek AA, El-Morsy A, et al
    Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesions.
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09091.
    >> Share

  25. CHEN G, Jiao D, Peng S, Chen X, et al
    Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09074.
    >> Share

  26. ZHOU C, Lu X, Wang Y, Qian X, et al
    Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
    Eur Radiol. 2022 Aug 17. pii: 10.1007/s00330-022-09065.
    >> Share


  27. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
    >> Share

    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
    >> Share

  29. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
    >> Share


  30. BYRNE CD, Targher G
    Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed.
    Gut. 2022;71:1695-1696.
    >> Share

  31. SIMON TG, Roelstraete B, Hagstrom H, Sundstrom J, et al
    Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Gut. 2022;71:1867-1875.
    >> Share


  32. SERPER M, Kaplan DE, Taddei TH, Tapper EB, et al
    Non-selective Beta Blockers, Hepatic Decompensation and Mortality in Cirrhosis: A National Cohort Study.
    Hepatology. 2022 Aug 19. doi: 10.1002/hep.32737.
    >> Share

  33. DEMORY A, Peron JM, Calderaro J, Selves J, et al
    Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
    Hepatology. 2022 Aug 18. doi: 10.1002/hep.32734.
    >> Share

  34. LOUREIRO D, Tout I, Narguet S, Bed CM, et al
    Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C or nonalcoholic steatohepatitis.
    Hepatology. 2022 Aug 16. doi: 10.1002/hep.32731.
    >> Share

    Indian J Gastroenterol

  35. YASMIN A, Rukunuzzaman M, Karim ASMB, Alam R, et al
    Ratio of aspartate aminotransferase to alanine aminotransferase and alkaline phosphatase to total bilirubin in Wilsonian acute liver failure in children.
    Indian J Gastroenterol. 2022;41:224-230.
    >> Share

    J Clin Oncol

  36. RAPHAEL MJ, Karanicolas PJ
    Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
    J Clin Oncol. 2022 Jun 1:JCO2102505. doi: 10.1200/JCO.21.02505.
    >> Share

    J Hepatol

  37. GEHRING AJ, MacParland SA
    Intrahepatic T cells with NK-like properties: expanding the repertoire of lymphocytes sensitive to bystander activation.
    J Hepatol. 2022 Aug 12. pii: S0168-8278(22)02985.
    >> Share

  38. DEGASPERI E, Anolli MP, Uceda Renteria SC, Sambarino D, et al
    Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension.
    J Hepatol. 2022 Aug 13. pii: S0168-8278(22)02980.
    >> Share

  39. AGGARWAL A, Montanari NR, Ramirez R, Diehl L, et al
    Reply to: Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection.
    J Hepatol. 2022 Aug 14. pii: S0168-8278(22)03000.
    >> Share

  40. BAILEY AL, Diamond MS
    Hepatopathology of flaviviruses.
    J Hepatol. 2022 Aug 15. pii: S0168-8278(22)00339.
    >> Share

  41. JI D, Chen Y, Bi J, Shang Q, et al
    Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
    J Hepatol. 2022 Aug 16. pii: S0168-8278(22)02982.
    >> Share

    J Pediatr Surg

  42. JIANG L, Wang N, Cheng S, Liu Y, et al
    RNA-sequencing identifies novel transcriptomic signatures in intestinal failure-associated liver disease.
    J Pediatr Surg. 2022;57:158-165.
    >> Share

  43. YILMAZ S, Kutluturk K, Koc C, Akbulut S, et al
    Letter to editor in response to: Management and outcome of hepatic artery thrombosis with whole-liver transplantation using donors less than one year of age.
    J Pediatr Surg. 2022 Aug 5. pii: S0022-3468(22)00504.
    >> Share


  44. GAO M, Qi Z, Deng M, Huang H, et al
    The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene. 2022;41:4018-4027.
    >> Share

    PLoS Genet

  45. KIYOSE H, Nakagawa H, Ono A, Aikata H, et al
    Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer.
    PLoS Genet. 2022;18:e1010342.
    >> Share

    PLoS One

  46. THI THU PN, Quynh MNT, Van HN, Thanh HN, et al
    A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor.
    PLoS One. 2022;17:e0272786.
    >> Share

  47. GURNEY J, Whitehead J, Kerrison C, Stanley J, et al
    Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand.
    PLoS One. 2022;17:e0269593.
    >> Share

  48. NIEHUES MB, Tomaz LA, Ferreira MS, Baldassini WA, et al
    Assessment of corn wet distillers grains fed to crossbred bulls on feeding behavior, rumen morphology, liver abscesses and blood parameters.
    PLoS One. 2022;17:e0271461.
    >> Share

  49. CHENG J, Wang Z, Liu J, Dou C, et al
    Value of 3D printing technology combined with indocyanine green fluorescent navigation in complex laparoscopic hepatectomy.
    PLoS One. 2022;17:e0272815.
    >> Share


  50. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    >> Share

    Transplant Proc

  51. RASZEJA-WYSZOMIRSKA J, Niewinski G, Graczynska A, Morawiec S, et al
    Clinical Implication of Plasma CD163 in Patients With Acute-on-Chronic Liver Failure.
    Transplant Proc. 2022;54:1011-1016.
    >> Share

  52. FIGIEL W, Smoter P, Krasnodebski M, Rykowski P, et al
    The Utility of Early Allograft Dysfunction Components in Determining 90-Day Liver Graft Survival.
    Transplant Proc. 2022;54:1017-1020.
    >> Share

  53. KOSCIELSKA M, Matuszkiewicz-Rowinska J, Giercuszkiewicz D, Krawczyk M, et al
    Simultaneous Liver-Kidney Transplantation and the Use of Intraoperative Dialysis: A Monocenter Study.
    Transplant Proc. 2022 Apr 11. pii: S0041-1345(22)00183.
    >> Share

  54. ROVGALIYEV B, Tan MY, Lee KW, Oh SC, et al
    Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Transplant Proc. 2022 Aug 14. pii: S0041-1345(22)00449.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016